Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas
T-cell lymphomas are highly heterogeneous and their prognosis is poor under the currently available therapies. Enhancers of zeste homologue 1 and 2 (EZH1/2) are histone H3 lysine-27 trimethyltransferases (H3K27me3). Despite the rapid development of new drugs inhibiting EZH2 and/or EZH1, the molecula...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 December 2021
|
| In: |
Biomedicines
Year: 2021, Jahrgang: 9, Heft: 12, Pages: 1-16 |
| ISSN: | 2227-9059 |
| DOI: | 10.3390/biomedicines9121842 |
| Online-Zugang: | Resolving-System, kostenfrei: https://doi.org/10.3390/biomedicines9121842 Resolving-System, kostenfrei: https://www.mdpi.com/2227-9059/9/12/1842 
|
| Verfasserangaben: | Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, Christian Rohde, Sarah Sandmann, Denis Terziev, Lutz P. Müller, Guido Posern, Andreas Wienke, Falko Fend, Martin-Leo Hansmann, Wolfram Klapper, Andreas Rosenwald, Harald Stein, Martin Dugas, Carsten Müller-Tidow, Claudia Wickenhauser, Mascha Binder, Thomas Weber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1811291864 | ||
| 003 | DE-627 | ||
| 005 | 20250109052355.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220721s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biomedicines9121842 |2 doi | |
| 035 | |a (DE-627)1811291864 | ||
| 035 | |a (DE-599)KXP1811291864 | ||
| 035 | |a (OCoLC)1341464379 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schümann, Franziska Lea |d 1997- |e VerfasserIn |0 (DE-588)1263179665 |0 (DE-627)1811293514 |4 aut | |
| 245 | 1 | 0 | |a Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas |c Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, Christian Rohde, Sarah Sandmann, Denis Terziev, Lutz P. Müller, Guido Posern, Andreas Wienke, Falko Fend, Martin-Leo Hansmann, Wolfram Klapper, Andreas Rosenwald, Harald Stein, Martin Dugas, Carsten Müller-Tidow, Claudia Wickenhauser, Mascha Binder, Thomas Weber |
| 264 | 1 | |c 5 December 2021 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.07.2022 | ||
| 520 | |a T-cell lymphomas are highly heterogeneous and their prognosis is poor under the currently available therapies. Enhancers of zeste homologue 1 and 2 (EZH1/2) are histone H3 lysine-27 trimethyltransferases (H3K27me3). Despite the rapid development of new drugs inhibiting EZH2 and/or EZH1, the molecular interplay of these proteins and the impact on disease progression and prognosis of patients with T-cell lymphomas remains insufficiently understood. In this study, EZH1/2 mutation status was evaluated in 33 monomorphic epitheliotropic intestinal T-cell lymphomas by next generation sequencing and EZH1/2 and H3K27me3 protein expression levels were detected by immunohistochemistry in 46 T-cell lymphomas. Correlations with clinicopathologic features were analyzed and survival curves generated. No EZH1 mutations and one (3%) EZH2 missense mutation were identified. In univariable analysis, high EZH1 expression was associated with an improved overall survival (OS) and progression-free survival (PFS) whereas high EZH2 and H3K27me3 expression were associated with poorer OS and PFS. Multivariable analysis revealed EZH1 (hazard ratio (HR) = 0.183; 95% confidence interval (CI): 0.044-0.767; p = 0.020;) and EZH2 (HR = 8.245; 95% CI: 1.898-35.826; p = 0.005) to be independent, divergent prognostic markers for OS. In conclusion, EZH1/2 protein expression had opposing effects on the prognosis of T-cell lymphoma patients. | ||
| 540 | |q DE-3 |a Namensnennung 4.0 International |f CC BY 4.0 |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 650 | 4 | |a epigenetics | |
| 650 | 4 | |a EZH1 | |
| 650 | 4 | |a EZH2 | |
| 650 | 4 | |a H3K27me3 | |
| 650 | 4 | |a immunohistochemistry | |
| 650 | 4 | |a next generation sequencing | |
| 650 | 4 | |a PTCL | |
| 650 | 4 | |a T-cell non-Hodgkin’s lymphomas | |
| 700 | 1 | |a Groß, Elisabeth |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bauer, Marcus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rohde, Christian |e VerfasserIn |0 (DE-588)1164191675 |0 (DE-627)1028653816 |0 (DE-576)508428939 |4 aut | |
| 700 | 1 | |a Sandmann, Sarah |d 1991- |e VerfasserIn |0 (DE-588)1151271616 |0 (DE-627)1011464985 |0 (DE-576)497583208 |4 aut | |
| 700 | 1 | |a Terziev, Denis |e VerfasserIn |0 (DE-588)1186086920 |0 (DE-627)1665354038 |4 aut | |
| 700 | 1 | |a Müller, Lutz P. |d 1970- |e VerfasserIn |0 (DE-588)122936248 |0 (DE-627)706097882 |0 (DE-576)293483248 |4 aut | |
| 700 | 1 | |a Posern, Guido |d 1968- |e VerfasserIn |0 (DE-588)121902749 |0 (DE-627)705696189 |0 (DE-576)292983603 |4 aut | |
| 700 | 1 | |a Wienke, Andreas |d 1966- |e VerfasserIn |0 (DE-588)115433872 |0 (DE-627)077250435 |0 (DE-576)289881935 |4 aut | |
| 700 | 1 | |a Fend, Falko |e VerfasserIn |0 (DE-588)112383363X |0 (DE-627)877479399 |0 (DE-576)482148225 |4 aut | |
| 700 | 1 | |8 1\p |a Hansmann, Martin-Leo |d 1949- |e VerfasserIn |0 (DE-588)1309980152 |0 (DE-627)1870371070 |4 aut | |
| 700 | 1 | |a Klapper, Wolfram |d 1971- |e VerfasserIn |0 (DE-588)123029880 |0 (DE-627)082304327 |0 (DE-576)293526842 |4 aut | |
| 700 | 1 | |a Rosenwald, Andreas |d 1967- |e VerfasserIn |0 (DE-588)1111788189 |0 (DE-627)865894868 |0 (DE-576)476255104 |4 aut | |
| 700 | 1 | |a Stein, Harald |d 1942- |e VerfasserIn |0 (DE-588)1124104275 |0 (DE-627)877828105 |0 (DE-576)482305177 |4 aut | |
| 700 | 1 | |a Dugas, Martin |e VerfasserIn |0 (DE-588)1131361393 |0 (DE-627)886028701 |0 (DE-576)487948939 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Wickenhauser, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Binder, Mascha |d 1978- |e VerfasserIn |0 (DE-588)129547824 |0 (DE-627)472306049 |0 (DE-576)188528881 |4 aut | |
| 700 | 1 | |a Weber, Thomas |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomedicines |d Basel : MDPI, 2013 |g 9(2021), 12, Artikel-ID 1842, Seite 1-16 |h Online-Ressource |w (DE-627)750370483 |w (DE-600)2720867-9 |w (DE-576)384589596 |x 2227-9059 |7 nnas |a Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:12 |g elocationid:1842 |g pages:1-16 |g extent:16 |a Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas |
| 856 | 4 | 0 | |u https://doi.org/10.3390/biomedicines9121842 |x Resolving-System |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/2227-9059/9/12/1842 |x Resolving-System |z kostenfrei |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20220721 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 16 | ||
| 998 | |g 1131361393 |a Dugas, Martin |m 1131361393:Dugas, Martin |d 910000 |d 911810 |e 910000PD1131361393 |e 911810PD1131361393 |k 0/910000/ |k 1/910000/911810/ |p 15 | ||
| 998 | |g 1164191675 |a Rohde, Christian |m 1164191675:Rohde, Christian |d 910000 |d 910100 |e 910000PR1164191675 |e 910100PR1164191675 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1811291864 |e 4171558891 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Franziska Lea","role":"aut","family":"Schümann","display":"Schümann, Franziska Lea"},{"given":"Elisabeth","role":"aut","family":"Groß","display":"Groß, Elisabeth"},{"display":"Bauer, Marcus","family":"Bauer","role":"aut","given":"Marcus"},{"display":"Rohde, Christian","family":"Rohde","role":"aut","given":"Christian"},{"role":"aut","given":"Sarah","family":"Sandmann","display":"Sandmann, Sarah"},{"role":"aut","given":"Denis","family":"Terziev","display":"Terziev, Denis"},{"role":"aut","given":"Lutz P.","display":"Müller, Lutz P.","family":"Müller"},{"given":"Guido","role":"aut","display":"Posern, Guido","family":"Posern"},{"family":"Wienke","display":"Wienke, Andreas","given":"Andreas","role":"aut"},{"display":"Fend, Falko","family":"Fend","role":"aut","given":"Falko"},{"display":"Hansmann, Martin-Leo","family":"Hansmann","role":"aut","given":"Martin-Leo"},{"family":"Klapper","display":"Klapper, Wolfram","role":"aut","given":"Wolfram"},{"family":"Rosenwald","display":"Rosenwald, Andreas","role":"aut","given":"Andreas"},{"display":"Stein, Harald","family":"Stein","role":"aut","given":"Harald"},{"family":"Dugas","display":"Dugas, Martin","given":"Martin","role":"aut"},{"role":"aut","given":"Carsten","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"},{"family":"Wickenhauser","display":"Wickenhauser, Claudia","role":"aut","given":"Claudia"},{"family":"Binder","display":"Binder, Mascha","role":"aut","given":"Mascha"},{"given":"Thomas","role":"aut","family":"Weber","display":"Weber, Thomas"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 21.07.2022"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"5 December 2021"}],"title":[{"title":"Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas","title_sort":"Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomas"}],"id":{"doi":["10.3390/biomedicines9121842"],"eki":["1811291864"]},"relHost":[{"part":{"text":"9(2021), 12, Artikel-ID 1842, Seite 1-16","issue":"12","pages":"1-16","year":"2021","extent":"16","volume":"9"},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Divergent effects of EZH1 and EZH2 protein expression on the prognosis of patients with T-cell lymphomasBiomedicines","title":[{"subtitle":"open access journal","title_sort":"Biomedicines","title":"Biomedicines"}],"origin":[{"dateIssuedKey":"2013","publisher":"MDPI","dateIssuedDisp":"2013-","publisherPlace":"Basel"}],"note":["Gesehen am 12.08.20"],"pubHistory":["1.2013 -"],"id":{"zdb":["2720867-9"],"issn":["2227-9059"],"eki":["750370483"]},"recId":"750370483","physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1811291864","name":{"displayForm":["Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, Christian Rohde, Sarah Sandmann, Denis Terziev, Lutz P. Müller, Guido Posern, Andreas Wienke, Falko Fend, Martin-Leo Hansmann, Wolfram Klapper, Andreas Rosenwald, Harald Stein, Martin Dugas, Carsten Müller-Tidow, Claudia Wickenhauser, Mascha Binder, Thomas Weber"]},"physDesc":[{"extent":"16 S."}]} | ||
| SRT | |a SCHUEMANNFDIVERGENTE5202 | ||